The Roles of Platelet GPIIb/IIIa and αvβ3 Integrins during HeLa Cells Adhesion, Migration, and Invasion to Monolayer Endothelium under Static and Dynamic Shear Flow

During their passage through the circulatory system, tumor cells undergo extensive interactions with various host cells including endothelial cells and platelets. Mechanisms mediating tumor cell adhesion, migration, and metastasis to vessel wall under flow condition are largely unknown. The aim of this study was to investigate the potential roles of GPIIb/IIIa and αvβ3 integrins underlying the HeLa-endothelium interaction in static and dynamic flow conditions. HeLa cell migration and invasion were studied by using Millicell cell culture insert system. The numbers of transmigrated or invaded HeLa cells significantly increased by thrombin-activated platelets and reduced by eptifibatide, a platelet inhibitor. Meanwhile, RGDWE peptides, a specific inhibitor of αvβ3 integrin, also inhibited HeLa cell transmigration. Interestingly, the presence of endothelial cells had significant effect on HeLa cell migration regardless of static or cocultured flow condition. The adhesion capability of HeLa cells to endothelial monolayer was also significantly affected by GPIIb/IIIa and αvβ3 integrins. The arrested HeLa cells increased nearly 5-fold in the presence of thrombin-activated platelets at shear stress condition (1.84 dyn/cm2 exposure for 1 hour) than the control (static). Our findings showed that GPIIb/IIIa and αvβ3 integrins are important mediators in the pathology of cervical cancer and provide a molecular basis for the future therapy, and the efficient antitumor benefit should target multiple receptors on tumor cells and platelets.

[1]  J. Huot,et al.  Mechanisms by which E-selectin regulates diapedesis of colon cancer cells under flow conditions. , 2008, Cancer research.

[2]  L. Horstman,et al.  Platelet aggregates as markers of platelet activation: Characterization of flow cytometric method suitable for clinical applications , 1998, American journal of hematology.

[3]  M. Basson,et al.  Increased extracellular pressure enhances cancer cell integrin-binding affinity through phosphorylation of beta1-integrin at threonine 788/789. , 2009, American journal of physiology. Cell physiology.

[4]  J. Heemskerk,et al.  Multiple ways to switch platelet integrins on and off , 2008, Journal of thrombosis and haemostasis : JTH.

[5]  Hong Yang,et al.  Effects of vascular endothelial growth factor (VEGF) and chondroitin sulfate A on human monocytic THP-1 cell migration. , 2005, Colloids and surfaces. B, Biointerfaces.

[6]  K. Lawler,et al.  Shear stress modulates the interaction of platelet-secreted matrix proteins with tumor cells through the integrin αvβ3 , 2004 .

[7]  Douglas W DeSimone,et al.  Cell adhesion receptors in mechanotransduction. , 2008, Current opinion in cell biology.

[8]  Tetsuya Shimizu,et al.  Prognostic impact of thrombocytosis in resectable non-small cell lung cancer. , 2008, Interactive cardiovascular and thoracic surgery.

[9]  T. Tsuruo,et al.  Tumorigenesis and Neoplastic Progression The Platelet Aggregation-Inducing Factor Aggrus / Podoplanin Promotes Pulmonary Metastasis , 2007 .

[10]  J. Degen,et al.  Platelets and fibrin(ogen) increase metastatic potential by impeding natural killer cell-mediated elimination of tumor cells. , 2005, Blood.

[11]  S. Usami,et al.  Analysis of the effect of disturbed flow on monocytic adhesion to endothelial cells. , 2002, Journal of biomechanics.

[12]  N. Kieffer,et al.  Integrin αvβ3 expression confers on tumor cells a greater propensity to metastasize to bone , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[13]  O. McCarty,et al.  Comparative Antiplatelet Efficacy of a Novel, Nonpeptide GPIIb/IIIa Antagonist (XV454) and Abciximab (c7E3) in Flow Models of Thrombosis , 2001, Arteriosclerosis, thrombosis, and vascular biology.

[14]  B. Nieswandt,et al.  Loss of talin1 in platelets abrogates integrin activation, platelet aggregation, and thrombus formation in vitro and in vivo , 2007, The Journal of experimental medicine.

[15]  R. Baron,et al.  Tumor αvβ3 Integrin Is a Therapeutic Target for Breast Cancer Bone Metastases , 2007 .

[16]  Cheng Dong,et al.  Shear stress and shear rate differentially affect the multi-step process of leukocyte-facilitated melanoma adhesion. , 2005, Experimental cell research.

[17]  Klaus Ley,et al.  Cells on the run: shear-regulated integrin activation in leukocyte rolling and arrest on endothelial cells. , 2008, Current opinion in cell biology.

[18]  C. Remacle,et al.  Circulating activated platelets assist THP-1 monocytoid/endothelial cell interaction under shear stress. , 1999, Blood.

[19]  M. Wojtukiewicz,et al.  Inhibition of platelet function: does it offer a chance of better cancer progression control? , 2007, Seminars in thrombosis and hemostasis.

[20]  Zaverio M. Ruggeri,et al.  Role of 3 Integrins in Melanoma Cell Adhesion to Activated Platelets under Flow (*) , 1996, The Journal of Biological Chemistry.

[21]  K. Konstantopoulos,et al.  Colon carcinoma cell glycolipids, integrins, and other glycoproteins mediate adhesion to HUVECs under flow. , 2003, American journal of physiology. Cell physiology.

[22]  J. Pilch,et al.  Unique Ability of Integrin αvβ3 to Support Tumor Cell Arrest under Dynamic Flow Conditions* 210 , 2002, The Journal of Biological Chemistry.

[23]  B. Echtenacher,et al.  Lysis of tumor cells by natural killer cells in mice is impeded by platelets. , 1999, Cancer research.

[24]  A. Ordinas,et al.  Platelet contribution to the formation of metastatic foci: the role of cancer cell-induced platelet activation. , 1988, Haemostasis.

[25]  O. McCarty,et al.  Fluid shear regulates the kinetics and molecular mechanisms of activation-dependent platelet binding to colon carcinoma cells. , 2002, Biophysical journal.

[26]  J. Chiu,et al.  A model for studying the effect of shear stress on interactions between vascular endothelial cells and smooth muscle cells. , 2004, Journal of biomechanics.

[27]  A. Saven,et al.  Activated integrin αvβ3 cooperates with metalloproteinase MMP-9 in regulating migration of metastatic breast cancer cells , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[28]  J. Rosa,et al.  A point mutation in the integrin beta 3 cytoplasmic domain (S752-->P) impairs bidirectional signaling through alpha IIb beta 3 (platelet glycoprotein IIb-IIIa). , 1994, Blood.

[29]  N. Watanabe,et al.  Reconstructing and Deconstructing Agonist-Induced Activation of Integrin αIIbβ3 , 2006, Current Biology.

[30]  M. Wojtukiewicz,et al.  Platelets and angiogenesis in malignancy. , 2004, Seminars in thrombosis and hemostasis.

[31]  J. Harlan,et al.  Adhesion of Activated Platelets to Endothelial Cells: Evidence for a GPIIbIIIa-dependent Bridging Mechanism and Novel Roles for Endothelial Intercellular Adhesion Molecule 1 (ICAM-1), αvβ3 Integrin, and GPIbα , 1998, The Journal of experimental medicine.

[32]  S. Coughlin,et al.  Mechanisms and consequences of agonist-induced talin recruitment to platelet integrin αIIbβ3 , 2008, The Journal of cell biology.

[33]  T. Huang,et al.  The Arg-Gly-Asp-containing peptide, rhodostomin, inhibits in vitro cell adhesion to extracellular matrices and platelet aggregation caused by saos-2 human osteosarcoma cells. , 1995, British Journal of Cancer.

[34]  M. Basson.  An intracellular signal pathway that regulates cancer cell adhesion in response to extracellular forces. , 2008, Cancer research.

[35]  Ruth J. Muschel,et al.  Coagulation Facilitates Tumor Cell Spreading in the Pulmonary Vasculature during Early Metastatic Colony Formation , 2004, Cancer Research.